CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expressed by other breast cancer subtypes. This pheno...

Full description

Bibliographic Details
Main Authors: Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, Maral Mahboubi Kancha, Milad Ahmadi Najafabadi, Faeze Salem, Setareh Dashti Shokoohi, Sahar Evazi Bakhshi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
triple-negative breast cancer
chimeric antigen receptor
solid tumors
cancer immunotherapy
adoptive cell therapy
T-cell therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1018786/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1018786/full

Similar Items